Retinal vein occlusion: C-reactive protein and arterial hypertension

Acta Ophthalmologica
|February 1, 1984
PubMed

Insights

Inflammation markers like C-reactive protein (CRP) are elevated in patients with hypertension or retinal vein occlusion. Hypertensive patients with high CRP may face a greater risk of developing retinal vein occlusion.

Area of Science:

  • Ophthalmology
  • Cardiovascular Medicine
  • Clinical Immunology

Background:

  • Retinal vein occlusion (RVO) and essential arterial hypertension are significant vascular conditions.
  • Inflammatory markers are increasingly recognized as potential contributors to vascular diseases.

Purpose of the Study:

  • To investigate serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and plasma viscosity in patients with RVO and hypertension.
  • To determine if elevated inflammatory markers are associated with an increased risk of RVO in hypertensive individuals.

Main Methods:

  • Serum CRP levels (log10 values), ESR, and plasma viscosity were measured.
  • Patients with RVO (central and branch) and treated essential hypertension were compared to an age-matched control group.
  • Statistical analysis was performed to compare marker levels between groups.

Main Results:

  • Serum CRP levels were significantly elevated in both hypertension and RVO groups compared to controls (P < 0.001).
  • Patients with both hypertension and RVO exhibited the highest mean CRP levels.
  • ESR and serum CRP were significantly higher in hypertensive RVO patients compared to normotensive RVO patients and controls (P < 0.05 and P < 0.01, P < 0.001).

Conclusions:

  • Increased inflammatory activity, indicated by elevated CRP and ESR, is associated with hypertension and RVO.
  • Hypertensive patients with elevated serum CRP may have a heightened risk of developing retinal vein occlusion.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...